Experience with portal-enteric pancreas transplant at the University of Tennessee-Memphis.

R. J. Stratta, A. O. Gaber, M. H. Shokouh-Amiri, M. F. Egidi, H. P. Grewal, K. S. Reddy, Donna Hathaway, R. P. Winsett, R. R. Alloway, L. W. Gaber, L. G. Britt

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The UT-Memphis Group has made a number of important contributions to the field of PTX including: 1. Pioneering studies on the effects of PTX on autonomic neuropathy;(15, 16) 2. Comprehensive reports dealing with quality of life after PTX;(17, 18, 38) 3. Seminal studies on the metabolic effects of PTX with portal venous delivery of insulin;(33,34) 4. Refining and perfecting a novel technique of PTX with portal venous drainage of insulin and primary enteric drainage of the exocrine secretions;(2,6,11,19) 5. Describing a percutaneous technique of pancreas biopsy;(20) and 6. Pioneering the use of glucose tolerance for rejection surveillance.(24) The P-E technique has the potential to become the standard of care in the near future because it is more physiologic, normalizes carbohydrate and lipid metabolism, and minimizes complications attributed to the transplant procedure. In addition, we have been actively involved in studying new immunosuppressive regimens in order to improve and simplify the care of the PTX recipient. We believe that PTX will remain an important option in the treatment of IDDM until other strategies are developed that can provide equal glycemic control with less or no immunosuppression or less overall morbidity.

Original languageEnglish (US)
Pages (from-to)239-253
Number of pages15
JournalClinical transplants
StatePublished - Jan 1 1998

Fingerprint

Drainage
Pancreas
Insulin
Transplants
Carbohydrate Metabolism
Standard of Care
Immunosuppressive Agents
Type 1 Diabetes Mellitus
Lipid Metabolism
Immunosuppression
Quality of Life
Morbidity
Biopsy
Glucose
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Stratta, R. J., Gaber, A. O., Shokouh-Amiri, M. H., Egidi, M. F., Grewal, H. P., Reddy, K. S., ... Britt, L. G. (1998). Experience with portal-enteric pancreas transplant at the University of Tennessee-Memphis. Clinical transplants, 239-253.

Experience with portal-enteric pancreas transplant at the University of Tennessee-Memphis. / Stratta, R. J.; Gaber, A. O.; Shokouh-Amiri, M. H.; Egidi, M. F.; Grewal, H. P.; Reddy, K. S.; Hathaway, Donna; Winsett, R. P.; Alloway, R. R.; Gaber, L. W.; Britt, L. G.

In: Clinical transplants, 01.01.1998, p. 239-253.

Research output: Contribution to journalArticle

Stratta, RJ, Gaber, AO, Shokouh-Amiri, MH, Egidi, MF, Grewal, HP, Reddy, KS, Hathaway, D, Winsett, RP, Alloway, RR, Gaber, LW & Britt, LG 1998, 'Experience with portal-enteric pancreas transplant at the University of Tennessee-Memphis.', Clinical transplants, pp. 239-253.
Stratta RJ, Gaber AO, Shokouh-Amiri MH, Egidi MF, Grewal HP, Reddy KS et al. Experience with portal-enteric pancreas transplant at the University of Tennessee-Memphis. Clinical transplants. 1998 Jan 1;239-253.
Stratta, R. J. ; Gaber, A. O. ; Shokouh-Amiri, M. H. ; Egidi, M. F. ; Grewal, H. P. ; Reddy, K. S. ; Hathaway, Donna ; Winsett, R. P. ; Alloway, R. R. ; Gaber, L. W. ; Britt, L. G. / Experience with portal-enteric pancreas transplant at the University of Tennessee-Memphis. In: Clinical transplants. 1998 ; pp. 239-253.
@article{09d8e43c807b461194acf15d67901093,
title = "Experience with portal-enteric pancreas transplant at the University of Tennessee-Memphis.",
abstract = "The UT-Memphis Group has made a number of important contributions to the field of PTX including: 1. Pioneering studies on the effects of PTX on autonomic neuropathy;(15, 16) 2. Comprehensive reports dealing with quality of life after PTX;(17, 18, 38) 3. Seminal studies on the metabolic effects of PTX with portal venous delivery of insulin;(33,34) 4. Refining and perfecting a novel technique of PTX with portal venous drainage of insulin and primary enteric drainage of the exocrine secretions;(2,6,11,19) 5. Describing a percutaneous technique of pancreas biopsy;(20) and 6. Pioneering the use of glucose tolerance for rejection surveillance.(24) The P-E technique has the potential to become the standard of care in the near future because it is more physiologic, normalizes carbohydrate and lipid metabolism, and minimizes complications attributed to the transplant procedure. In addition, we have been actively involved in studying new immunosuppressive regimens in order to improve and simplify the care of the PTX recipient. We believe that PTX will remain an important option in the treatment of IDDM until other strategies are developed that can provide equal glycemic control with less or no immunosuppression or less overall morbidity.",
author = "Stratta, {R. J.} and Gaber, {A. O.} and Shokouh-Amiri, {M. H.} and Egidi, {M. F.} and Grewal, {H. P.} and Reddy, {K. S.} and Donna Hathaway and Winsett, {R. P.} and Alloway, {R. R.} and Gaber, {L. W.} and Britt, {L. G.}",
year = "1998",
month = "1",
day = "1",
language = "English (US)",
pages = "239--253",
journal = "Clinical transplants",
issn = "0890-9016",
publisher = "UCLA Immunogenetics Center",

}

TY - JOUR

T1 - Experience with portal-enteric pancreas transplant at the University of Tennessee-Memphis.

AU - Stratta, R. J.

AU - Gaber, A. O.

AU - Shokouh-Amiri, M. H.

AU - Egidi, M. F.

AU - Grewal, H. P.

AU - Reddy, K. S.

AU - Hathaway, Donna

AU - Winsett, R. P.

AU - Alloway, R. R.

AU - Gaber, L. W.

AU - Britt, L. G.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - The UT-Memphis Group has made a number of important contributions to the field of PTX including: 1. Pioneering studies on the effects of PTX on autonomic neuropathy;(15, 16) 2. Comprehensive reports dealing with quality of life after PTX;(17, 18, 38) 3. Seminal studies on the metabolic effects of PTX with portal venous delivery of insulin;(33,34) 4. Refining and perfecting a novel technique of PTX with portal venous drainage of insulin and primary enteric drainage of the exocrine secretions;(2,6,11,19) 5. Describing a percutaneous technique of pancreas biopsy;(20) and 6. Pioneering the use of glucose tolerance for rejection surveillance.(24) The P-E technique has the potential to become the standard of care in the near future because it is more physiologic, normalizes carbohydrate and lipid metabolism, and minimizes complications attributed to the transplant procedure. In addition, we have been actively involved in studying new immunosuppressive regimens in order to improve and simplify the care of the PTX recipient. We believe that PTX will remain an important option in the treatment of IDDM until other strategies are developed that can provide equal glycemic control with less or no immunosuppression or less overall morbidity.

AB - The UT-Memphis Group has made a number of important contributions to the field of PTX including: 1. Pioneering studies on the effects of PTX on autonomic neuropathy;(15, 16) 2. Comprehensive reports dealing with quality of life after PTX;(17, 18, 38) 3. Seminal studies on the metabolic effects of PTX with portal venous delivery of insulin;(33,34) 4. Refining and perfecting a novel technique of PTX with portal venous drainage of insulin and primary enteric drainage of the exocrine secretions;(2,6,11,19) 5. Describing a percutaneous technique of pancreas biopsy;(20) and 6. Pioneering the use of glucose tolerance for rejection surveillance.(24) The P-E technique has the potential to become the standard of care in the near future because it is more physiologic, normalizes carbohydrate and lipid metabolism, and minimizes complications attributed to the transplant procedure. In addition, we have been actively involved in studying new immunosuppressive regimens in order to improve and simplify the care of the PTX recipient. We believe that PTX will remain an important option in the treatment of IDDM until other strategies are developed that can provide equal glycemic control with less or no immunosuppression or less overall morbidity.

UR - http://www.scopus.com/inward/record.url?scp=0032235187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032235187&partnerID=8YFLogxK

M3 - Article

SP - 239

EP - 253

JO - Clinical transplants

JF - Clinical transplants

SN - 0890-9016

ER -